Heba Degheidy, M.D., Ph.D., a visiting research associate at FDA, works with stem cell samples in an FDA laboratory on the National Institutes of Health campus
The U.S. Food and Drug Administration (Wikimedia Commons) / Public domain
Clinical Trials/October 16, 2026/3 min read

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

  • METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) — RECRUITING, PHASE2. Interventions: AMX0035, Placebo. Locations: Seattle, Washington, United States | Amsterdam, Netherlands. The study is a randomized, double-blind, parallel-group clinical trial to examine the effects...Source
  • Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App — RECRUITING, NA. Interventions: SmartGuide CGM without Predict App, SmartGuide CGM with Predict App. Locations: Bad Mergentheim, Baden-Wurttemberg, Germany. The goal of this controlled pre-post-trial is to test the Accu-...Source
  • Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody — RECRUITING, PHASE2. Interventions: ex vivo expanded CD4+CD25+CD127- regulatory T cells (Tregs), Anti-CD20 (rituximab), Placebo. Locations: Bialystok, Poland | Gdansk, Poland | Katowice, Poland. The main purpose of the s...Source
  • Long Term Follow up of Recipients of Functional Islet Allografts — RECRUITING. Locations: Miami, Florida, United States. Since its inception, the Diabetes Research Institute (DRI) has made significant contributions to the field of diabetes, pioneering many of the techniques used in dia...Source
  • Dysautonomia in Children With Type 1 Diabetes — RECRUITING, NA. Interventions: Neurocoach® and Sudoscan®. Locations: Saint-Etienne, France. Some physiological factors, such as physical activity, or pathological factors, such as sepsis or diabetes, are known to modula...Source
  • Type 1 Diabetes and Obstructive Sleep Apnea — RECRUITING, NA. Interventions: Continuous positive airway pressure (CPAP). Locations: Chicago, Illinois, United States. The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adu...Source
  • Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State — RECRUITING, PHASE1. Interventions: GZR-33. Locations: Neuss, Germany | Neuss, Germany. This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter refer...Source
  • Immunotherapy with Autologous Tregs in T1DM — RECRUITING, PHASE1. Interventions: Ex vivo Expanded Human Autologous Regulatory T Cells, Routine Care. Locations: Nanjing, Jiangsu, China. Type 1 diabetes (T1D) is an autoimmune disease characterized by a progressive im...Source

Questions before contacting a study

  • Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
  • What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
  • Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.